Corrigendum: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways.

Authors :: Quagliariello V
Passariello M
Di Mauro A
Cipullo C
Paccone A
Barbieri A
Palma G
Luciano A
Buccolo S
Bisceglia I
Canale ML
Gallucci G
Inno A
De Lorenzo C
Maurea N
Source :: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2023 Jan 19; Vol. 10, pp. 1129873. Date of Electronic Publication: 2023 Jan 19 (Print Publication: 2023).
Publication Year :: 2023
Abstract: [This corrects the article DOI: 10.3389/fcvm.2022.930797.].<br /> (Copyright © 2023 Quagliariello, Passariello, Di Mauro, Cipullo, Paccone, Barbieri, Palma, Luciano, Buccolo, Bisceglia, Canale, Gallucci, Inno, De Lorenzo and Maurea.)

Full Text Access

Tools